Observational analysis demonstrates improved hydroxyl radical generation in cancer treatment, suggesting enhanced therapeutic synergy.
Hydroxyl radicals (·OH) offer exceptional potential for cancer treatment through reactive oxygen species (ROS) amplification and apoptotic induction. However, conventional Fe-based metal–organic framework (Fe-MOF) nanomaterials are limited by inadequate Fe2+ concentrations, resulting in suboptimal Fenton catalytic performance. This study presents concave octahedral Fe-MOF nanomaterials with integrated bimetallic Fe/Zn centers through controlled solvothermal synthesis. The nanoplatform exhibits high specific surface area (559 m2/g) and 5-fluorouracil (5-FU) loading efficiency (58.7%). These structural properties establish it as a potential nanobuilding block for constructing stimuli-responsive gels. With optimized Fe2+ content (57.3%), the Fe-MOF material shows enhanced nanozyme-like activity (Vmax = 4.58 × 10−7 M/s, Kcat = 1.83 × 10−3 s−1) for H2O2-mediated ·OH generation. The Fe-MOF@FU demonstrates pH-responsive drug release (76.5% at pH 5.0) and glutathione (GSH) depletion, synergistically enhancing oxidative stress. Biocompatibility studies confirm safety, while in vitro investigations show remarkable anticancer activity against 4T1 cells with 17.8% viability, supporting its dual role as an independent therapeutic agent and a functional component for future gel-based delivery systems.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Gels